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Value of PCR as a de-escalation tool for an Antimicrobial Stewardship Program
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Methods

Background

29th,

 On January
2016, the facility acquired the
FilmArray Respiratory Panel (BioFire) TM
Diagnostics, Inc, the first multiplex polymerase
chain reaction (PCR) molecular panel approved by
the FDA for the detection of both bacterial and viral
respiratory pathogens.
 Sensitivity and specificity of this technology has
been reported as 80-100%, and 100%,
respectively1, allowing for an optimal approach in
the diagnosis of influenza and other organisms.
 An essential element of an Antimicrobial
Stewardship Program (ASP) as outlined by the
CDC and Joint Commission is to perform a
“48-hour timeout” to assess the patient for
opportunities, including de-escalation and
discontinuation of antimicrobials2.
 At our facility, we identified the need to review
patients prescribed oseltamivir and any associated
antibiotics for ASP opportunities. With the PCR
tool available pharmacists were educated through
an associated workflow to contact prescribers
(within 48 hours) for de-escalation of oseltamivir
when results were negative for influenza. For
influenza positive patients who were also
prescribed antibiotics, a procalcitonin level was
recommended, and if appropriate, antibiotic deescalation was suggested. Additionally,
pharmacists notified nursing to initiate or
discontinue droplet isolation based on the PCR
influenza results.

 This study was determined to be exempt by Baptist
Health South Florida Institutional Review Board.
 Single-center, retrospective chart review.
 Study period: October 1st, 2017 through March
31st, 2018.

 Patients with negative PCR and associated
antibiotics were not reviewed.
 30-day readmission was only assessed within the
Baptist Health South Florida (BHSF) system.
Conclusion

 Exclusion Criteria:
 Patients younger than 18 years of age
 Receiving oseltamivir with no associated
documented intervention.

 Successful antibiotic discontinuation for patients
with a positive PCR result and normal
procalcitonin was 63% (12/19).

 List generated for patients receiving oseltamivir
with an associated ASP intervention documented
was obtained from a data analytics platform.
 Charts were reviewed for PCR results, pharmacist
intervention data, procalcitonin levels, and 30-day
readmission rate.
 Group purchasing organization (GPO) pricing of
antimicrobials was utilized for estimated costsavings.
 Pharmacist Workflow:

Pharmacist interventions for negative PCR
showed a 71% (27/38) success rate in
discontinuation of oseltamivir within 48 hours.

 Pharmacy identified 14.9% (11/74) of patients
who required initiation of droplet isolation, and
20.3% (15/74) who did not need it.
 Overall, we estimated a total cost-saving of
$4,057.83 during the study period as a result of
pharmacist-driven ASP interventions.
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Disclosure

2. To determine intervention results by pharmacists
with regards to isolation requirements.
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 Only patients for whom an ASP intervention was
documented were included in this project.



1. To evaluate the effectiveness of pharmacist
interventions utilizing PCR results for patients
receiving oseltamivir and concurrent antibiotics
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Limitations

 Inclusion Criteria:
 Patients 18 years of age and older.
 Receiving oseltamivir with an associated
pharmacist intervention documented.

Objectives

3. Calculate potential cost-savings based on
intervention data.

Results

pct: procalcitonin
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